Tag: Verve PCSK9-inhibitor gene therapy

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Verve PCSK9-inhibitor gene therapy

CRISPR used for the first time to treat a disease in a baby - Science Media Centre

Added to Collection on: 2025-05-15 17:08:24

Tags for this article:

Biotechnology
Genetic engineering
Molecular biology
Genome editing
PCSK9
Biological engineering
Familial hypercholesterolemia
Kiran Musunuru
CRISPR
Verve PCSK9-inhibitor gene therapy
Gene therapy

Click the tags to see associated articles and topics

View Article Details
3 Top Genomics Stocks to Add to Your Portfolio in 2025 - TradingView

Added to Collection on: 2025-05-21 14:22:51

Tags for this article:

Biotechnology
Molecular biology
Genetic engineering
Molecular genetics
Genome editing
PCSK9
Intellia Therapeutics
Verve PCSK9-inhibitor gene therapy
Gene therapy
Familial hypercholesterolemia
CRISPR Therapeutics
Synthetic biology

Click the tags to see associated articles and topics

View Article Details
Verve Therapeutics (NASDAQ:VERV) Upgraded at Wall Street Zen - Defense World

Added to Collection on: 2025-05-25 19:46:24

Tags for this article:

Verve PCSK9-inhibitor gene therapy
PCSK9

Click the tags to see associated articles and topics

View Article Details
Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by Ameriprise Financial Inc.

Added to Collection on: 2025-06-01 07:28:35

Tags for this article:

Verve PCSK9-inhibitor gene therapy
PCSK9

Click the tags to see associated articles and topics

View Article Details
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics

Added to Collection on: 2025-06-18 10:31:35

Tags for this article:

Biotechnology
Applied genetics
Bioethics
Gene therapy
Molecular biology
Delandistrogene moxeparvovec
Duchenne muscular dystrophy
Verve PCSK9-inhibitor gene therapy
Pfizer-BioNTech COVID-19 vaccine
Therapy
BioNTech

Click the tags to see associated articles and topics

View Article Details
PCSK9-Targeted Therapy Market Size to Hit USD 28.71 Billion by 2034

Added to Collection on: 2025-07-08 13:57:30

Tags for this article:

PCSK9 inhibitors
PCSK9
Alirocumab
Familial hypercholesterolemia
Inclisiran
Evolocumab
Verve PCSK9-inhibitor gene therapy
Hyperlipidemia
Sanofi
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals
Low-density lipoprotein
CRISPR
United States

Click the tags to see associated articles and topics

View Article Details
Verve Therapeutics (VERV) Projected to Post Quarterly Earnings on Thursday

Added to Collection on: 2025-08-07 18:42:07

Tags for this article:

Alternative investment management companies
Institutional investors
Verve PCSK9-inhibitor gene therapy
Stock exchange
Hedge fund
Goldman Sachs
Verve Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo